Differences in interactions between azole drugs related to modifications in the 14-α sterol dernethylase gene (cyp51A) of Aspergillus fumigatus

被引：26
作者：
Garcia-Effron, G [1 ]
Mellado, E [1 ]
Gomez-Lopez, A [1 ]
Alcazar-Fuoli, L [1 ]
Cuenca-Estrella, A [1 ]
Rodriguez-Tudela, JL [1 ]
机构：
[1] Ctr Nacl Microbiol Virol & Inmunol Sanitarias Maja, Microbiol Serv, Inst Salud Carlos III, Madrid 28220, Spain
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2005年 / 49卷 / 05期
关键词：
D O I：
10.1128/AAC.49.5.2119-2121.2005
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
The combined activity of different azole drugs was investigated. Thirty-one Aspergillus fumigatus strains were tested, including two cyp51A(-) and one cyp51B(-) gene-knockout strain and azole-susceptible and -resistant strains with different resistance mechanisms. The combination of itraconazole and voriconazole was synergistic for all strains except for those with gene knockouts.
引用
收藏
页码：2119 / 2121
页数：3
相关论文
共 27 条
[1]   Potent synergistic in vitro interaction between nonantimicrobial membrane-active compounds and itraconazole against clinical isolates of Aspergillus fumigatus resistant to Itraconazole [J].
Afeltra, J ;
Vitale, RG ;
Mouton, JW ;
Verweij, PE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (04) :1335-1343
[2]   In vitro susceptibility of respiratory isolates of Aspergillus species to itraconazole and amphotericin B. Acquired resistance to itraconazole [J].
Chryssanthou, E .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1997, 29 (05) :509-512
[3]   Recent trends in the epidemiology of invasive mycoses [J].
Clark, TA ;
Hajjeh, RA .
CURRENT OPINION IN INFECTIOUS DISEASES, 2002, 15 (06) :569-574
[4]   In-vivo itraconazole resistance of Aspergillus fumigatus in systemic murine aspergillosis [J].
Dannaoui, E ;
Borel, E ;
Persat, F ;
Monier, MF ;
Piens, MA .
JOURNAL OF MEDICAL MICROBIOLOGY, 1999, 48 (12) :1087-1093
[5]   Itraconazole resistance in Aspergillus fumigatus [J].
Denning, DW ;
Venkateswarlu, K ;
Oakley, KL ;
Anderson, MJ ;
Manning, NJ ;
Stevens, DA ;
Warnock, DW ;
Kelly, SL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (06) :1364-1368
[6]   Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection [J].
Denning, DW ;
Radford, SA ;
Oakley, KL ;
Hall, L ;
Johnson, EM ;
Warnock, DW .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (03) :401-414
[7]   A point mutation in the 14α-sterol demethylase gene cyp51A contributes to itraconazole resistance in Aspergillus fumigatus [J].
Diaz-Guerra, TM ;
Mellado, E ;
Cuenca-Estrella, M ;
Rodriguez-Tudela, JL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (03) :1120-1124
[8]   Genetic control of resistance to the sterol 14α-demethylase inhibitor fungicide prochloraz in the cereal eyespot pathogen Tapesia yallundae [J].
Dyer, PS ;
Hansen, J ;
Delaney, A ;
Lucas, JA .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2000, 66 (11) :4599-4604
[9]   Antifungal agents: Mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance [J].
Ghannoum, MA ;
Rice, LB .
CLINICAL MICROBIOLOGY REVIEWS, 1999, 12 (04) :501-+
[10]   In vitro activities of three licensed antifungal agents against Spanish clinical isolates of Aspergillus spp. [J].
Gomez-Lopez, A ;
Garcia-Effron, G ;
Mellado, E ;
Monzon, A ;
Rodriguez-Tudela, JL ;
Cuenca-Estrella, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (10) :3085-3088
123